ETHICAL QUESTIONS AND PERSONAL CONFLICTS FOR THE PHYSICIAN IN THE CLINICAL-TESTING OF NEW PSYCHOACTIVE-DRUGS

被引：0
|
作者：
FUCHS, M
机构：
来源：
PSYCHOPHARMACOLOGIA | 1963年 / 5卷 / 01期
关键词：
D O I：
10.1007/BF00405576
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：77 / 83
页数：7
相关论文
共 50 条
  • [41] HERRICK,AD - CLINICAL TESTING OF NEW DRUGS
    不详
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1966, 252 (04): : 501 - &
  • [42] Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances
    Di Trana, Annagiulia
    Berardinelli, Diletta
    Montanari, Eva
    Berretta, Paolo
    Basile, Giuseppe
    Huestis, Marilyn A.
    Busardo, Francesco Paolo
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [43] Patents, profits & American medicine: conflicts of interest in the testing & marketing of new drugs
    Angell, M
    Relman, AS
    [J]. DAEDALUS, 2002, 131 (02) : 102 - 111
  • [44] Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication
    Grafinger, Katharina Elisabeth
    Liechti, Matthias E.
    Liakoni, Evangelia
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (03) : 429 - 436
  • [45] A NEW GLARE TESTER FOR CLINICAL-TESTING - RESULTS COMPARING NORMAL SUBJECTS AND VARIOUSLY CORRECTED APHAKIC PATIENTS
    LECLAIRE, J
    NADLER, MP
    WEISS, S
    MILLER, D
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1982, 100 (01) : 153 - 158
  • [46] CLINICAL-TESTING OF A NEW, LOW-FLUX POLYSULFONE MEMBRANE - RESULTS OF A 26-WEEK STUDY
    HONKANEN, E
    GRONHAGENRISKA, C
    TEPPO, AM
    HILTUNEN, U
    [J]. BLOOD PURIFICATION, 1989, 7 (05) : 240 - 246
  • [47] On obtaining informed consent in clinical testing -: Position of the Ethical and Legal Questions Research Group of the AGNP
    Nedopil, N
    Aldenhoff, J
    Amelung, K
    Eich, FX
    Fritze, J
    Gastpar, M
    Maier, W
    Möller, HJ
    [J]. PSYCHOPHARMAKOTHERAPIE, 1999, 6 (03): : 124 - 127
  • [48] PHYSICIANS LEGAL RESPONSIBILITY IN CLINICAL TESTING OF NEW DRUGS
    HATRY, P
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1963, 4 (01) : 4 - &
  • [49] Disillusionment bias in clinical trials testing new drugs
    Sanz Rubiales, A.
    Luisa Del Valle, M.
    [J]. CLINICAL ONCOLOGY, 2008, 20 (03) : 267 - 267
  • [50] Pharmacology should be at the centre of all preclinical and clinical studies on new psychoactive substances (recreational drugs)
    Green, A. Richard
    Nutt, David J.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (08) : 711 - 718
12345